| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/08/2022 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 2.2M | $3.50 | $7.5M | | 08/08/2022 |
| 12/06/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 1.8k | $6.90 | $12.6k | | 12/06/2021 |
| 12/02/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 4.3k | $6.88 | $29.6k | | 11/30/2021 |
| 12/01/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 18.4k | $6.85 | $125.8k | | 11/30/2021 |
| 11/30/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 28.6k | $6.85 | $195.8k | | 11/30/2021 |
| 11/29/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 11.1k | $6.89 | $76.2k | | 11/24/2021 |
| 11/26/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 27.3k | $6.81 | $185.5k | | 11/24/2021 |
| 11/24/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 1.1k | $6.89 | $7.3k | | 11/24/2021 |
| 11/23/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 14.6k | $6.77 | $99k | | 11/19/2021 |
| 11/19/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 11.1k | $7.44 | $82.7k | | 11/19/2021 |
| 11/18/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 71.3k | $7.18 | $511.7k | | 11/16/2021 |
| 11/17/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 280.4k | $7.21 | $2M | | 11/16/2021 |
| 11/16/2021 | Poseida Therapeutics, Inc. | PSTX | Purchase | COMMON STOCK | 27.7k | $7.17 | $198.4k | | 11/16/2021 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Series C Preferred Stock | 392.9k | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Series B Preferred Stock | 860.6k | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Series A-1 Preferred Stock | 1.5M | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Series A Preferred Stock | 8.7M | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Common Stock | 315.1k | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Common Stock | 690.1k | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 07/14/2020 |
| 07/14/2020 | Poseida Therapeutics, Inc. | PSTX | Conversion | Common Stock | 7M | $0.00 | $0 | | 07/14/2020 |
| 07/02/2019 | Novan, Inc. | NOVN | Sale | Common Stock | 6.3k | $2.75 | $17.3k | See Footnote | 06/28/2019 |
| 07/01/2019 | Novan, Inc. | NOVN | Sale | Common Stock | 913 | $2.74 | $2.5k | See Footnote | 06/28/2019 |
| 06/28/2019 | Novan, Inc. | NOVN | Sale | Common Stock | 17.8k | $2.69 | $47.9k | See Footnote | 06/28/2019 |